The Biote Method is purpose built to enable Biote-certified practitioners to treat hormone imbalance using bioidentical estrogen and testosterone products as necessary. The term bioidentical refers to hormone formulations that match the hormones of the human body. Estradiol (the most active estrogen), progesterone and testosterone can be produced as bioidentical formulations. Estradiol is FDA approved and commercially available under several different brand names. Examples include Vivelle Dot (patch), Estro ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number: 0 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 For the transition period from ______________ to ______________ Commission File Number: 001-40128 biote Corp. (Exact Name of Registrant as Specified in its Charter) ( State or other jurisdicti ...

Table of Contents Title of each classTrading Symbol(s)Name of each exchange on which registered Units, each consisting of one share of Class A Common Stock, par value $0.0001 per share, and one-fourth of one Redeemable Warrant HYACU The NASDAQ Stock Market LLC Class A Common Stock, par value $0.0001 per share HYAC The NASDAQ Stock Market LLC Warrants, each exercisable for one share of Class A Common Stock for $11.50 per share HYACW The NASDAQ Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...

Table of Contents Title of Each Class:Trading Symbol(s)Name of Each Exchange on Which Registered: Units, each consisting of one share of Class A common stock, par value $0.0001 per share, and one-fourth of one Redeemable Warrant HYACU The Nasdaq Stock Market LLC Shares of Class A common stock, par value $0.0001 per share, included as part of the Units HYAC The Nasdaq Stock Market LLC Redeemable Warrants included as part of the Units HYACW The Nasdaq Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COM ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each classTrading Symbol(s)Name of each exchange on which registered Units, each consisting of one share of Class A Common Stock, par value $0.0001 per share, and one-fourth of one Redeemable Warrant HYACU The NASDAQ Stock Market LLC Class A Common Stock, par value $0.0001 per share HYAC The NASDAQ Stock Market LLC Warrants, each exercisable for one share of Class A Common Stock for $11.50 per share HYACW The NASDAQ Stock Marke ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------ ...

Financial Performance - For the three months ended March 31, 2021, the company reported a net loss of $3,943,374, which included expensed offering costs of $962,447 and a loss on the sale of private placement warrants of $3,507,000[130]. - Net cash used in operating activities for the three months ended March 31, 2021, was $626,996, primarily due to the net loss and changes in operating assets and liabilities[133]. - The company has not generated any operating revenues to date and does not expect to do so until after the completion of its initial business combination[129]. Cash Position - As of March 31, 2021, the company had $922,484 in cash held outside of the Trust Account and a working capital balance of $1,490,920, excluding franchise tax payable[131]. - The company had no off-balance sheet arrangements as of March 31, 2021[136]. Investing and Financing Activities - The company had net cash used in investing activities of $317,500,000, attributed to the deposit of net proceeds from the initial public offering into the Trust Account[134]. - For the three months ended March 31, 2021, net cash provided by financing activities was $319,047,886, which included $311,150,000 from the issuance of units in the initial public offering[135]. - The underwriters were granted a 45-day option to purchase up to 4,500,000 additional Units, and on March 5, 2021, they purchased an additional 1,750,000 Units, generating gross proceeds of $17,500,000[139]. - The company incurred a cash underwriting fee of $6,350,000 and deferred underwriting commissions of $11,112,500, payable upon completion of a Business Combination[140]. Equity Structure - As of March 31, 2021, 27,485,793 shares of Class A common stock were subject to possible redemption, classified as temporary equity[142].